A clinical trial to study the effect of drug tranexamic acid in addition to oxytocin in reducing blood loss after vaginal delivery

A randomized double blind placebo control trial to assess whether tranexamic acid as prophylaxis lowers the risk of PPH in women delivering vaginally - nil

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2023/09/057612

Enrollment

Registered

2023-09-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Injection Tranexamic Acid: 1 gram slow intravenously within 1 minute of child birth Control Intervention1: Injection Oxytocin: 10 IU injection Oxytocin intramuscularly within 1 minute o

Eligibility

Inclusion criteria

Inclusion criteria: WOMEN PLANNED FOR VAGINAL DELIVERY

Exclusion criteria

Exclusion criteria: AGE < 18 YEARS

Design outcomes

Primary

Measure	Time frame
Blood loss after vaginal deliveryTimepoint: Within 1 hour after vaginal delivery	—

Secondary

Measure	Time frame
Haemoglobin levelTimepoint: After 24 hours of vaginal delivery	—

Countries

India

Contacts

Public ContactDR Kanchan Nema

Pt J N M Medical College Raipur

kishoreruchi62@gmail.com7024804784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026